# Dexcom (DXCM) — Analyst Forecast

DXCM · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/dxcm/forecast

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 12, 2026 | BTIG | Maintained | Buy | $96.00 |
| Oct 7, 2026 | Barclays | Initiated Coverage | Overweight | $115.00 |
| Oct 1, 2026 | RBC Capital | Maintained | Outperform | $105.00 |
| Sep 18, 2026 | Truist Securities | Maintained | Buy | $102.00 |
| Sep 18, 2026 | TD Cowen | Maintained | Buy | $95.00 |
| Aug 4, 2026 | Argus Research | Maintained | Buy | $96.00 |
| Aug 3, 2026 | Canaccord Genuity | Maintained | Buy | $90.00 |
| Jul 31, 2026 | Truist Securities | Maintained | Buy | $93.00 |
| Jul 31, 2026 | Benchmark | Maintained | Buy | $82.00 |
| Jul 31, 2026 | Stifel | Maintained | Buy | $95.00 |
| Jul 31, 2026 | Wells Fargo | Maintained | Overweight | $90.00 |
| Jul 31, 2026 | Piper Sandler | Maintained | Overweight | $95.00 |
| Jul 31, 2026 | BTIG | Maintained | Buy | $90.00 |
| Jul 31, 2026 | JP Morgan | Maintained | Neutral | $82.00 |
| Jul 31, 2026 | Mizuho | Maintained | Outperform | $95.00 |
| Jul 31, 2026 | RBC Capital | Maintained | Outperform | $90.00 |
| Jul 31, 2026 | Citigroup | Maintained | Buy | $88.00 |
| Jul 28, 2026 | UBS | Maintained | Buy | $96.00 |
| Jul 16, 2026 | Truist Securities | Maintained | Buy | $87.00 |
| Jul 15, 2026 | Mizuho | Maintained | Outperform | $90.00 |

## Frequently Asked Questions

### What is the latest analyst rating on DXCM?

On Oct 12, 2026, BTIG maintained Dexcom at Buy with a price target of $96.00.

## Similar Stocks

- [PODD](https://www.lighthorse.io/tickers/podd) — Insulet Corporation - Common Stock
- [ITGR](https://www.lighthorse.io/tickers/itgr) — Integer Holdings Corporation Common Stock
- [ABT](https://www.lighthorse.io/tickers/abt) — Abbott Laboratories Common Stock
- [HQY](https://www.lighthorse.io/tickers/hqy) — HealthEquity, Inc. - Common Stock
- [AMN](https://www.lighthorse.io/tickers/amn) — AMN Healthcare Services Inc

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).